- Investing Ideas
- /
- Chinese Healthcare Undervalued Stocks Based On Cash Flows
Chinese Healthcare Undervalued Stocks Based On Cash Flows
Results
4
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
Shanghai General Healthy Information and Technology
Market Cap: CN¥2.9b
Shanghai General Healthy Information and Technology Co., Ltd.
605186
CN¥21.00
7D
1.0%
1Y
15.6%
Shenzhen YHLO Biotech
Market Cap: CN¥8.6b
Researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally.
688575
CN¥15.28
7D
2.7%
1Y
-28.6%
Eyebright Medical Technology (Beijing)
Market Cap: CN¥15.3b
Eyebright Medical Technology (Beijing) Co., Ltd.
688050
CN¥79.66
7D
1.7%
1Y
-2.6%
Xiangyu MedicalLtd
Market Cap: CN¥8.5b
Engages in the research, development, manufacturing, and marketing of rehabilitation and physiotherapy equipment.
688626
CN¥55.35
7D
1.7%
1Y
142.4%